[go: up one dir, main page]

FI98343B - Peroraalinen formulaatio - Google Patents

Peroraalinen formulaatio

Info

Publication number
FI98343B
FI98343B FI951316A FI951316A FI98343B FI 98343 B FI98343 B FI 98343B FI 951316 A FI951316 A FI 951316A FI 951316 A FI951316 A FI 951316A FI 98343 B FI98343 B FI 98343B
Authority
FI
Finland
Prior art keywords
composition
drug
pct
controlling agent
release controlling
Prior art date
Application number
FI951316A
Other languages
English (en)
Swedish (sv)
Other versions
FI98343C (fi
FI951316A0 (fi
FI951316L (fi
Inventor
Martti Marvola
Esko Marttila
Reija Yrjoelae
Esa Lahdenpaeae
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of FI951316A0 publication Critical patent/FI951316A0/fi
Priority to FI951316A priority Critical patent/FI98343C/fi
Priority to PT96906784T priority patent/PT817615E/pt
Priority to DE69622850T priority patent/DE69622850T2/de
Priority to AT96906784T priority patent/ATE221771T1/de
Priority to JP8528112A priority patent/JPH11502217A/ja
Priority to EP96906784A priority patent/EP0817615B1/en
Priority to ES96906784T priority patent/ES2181874T3/es
Priority to CA002213747A priority patent/CA2213747A1/en
Priority to US08/913,554 priority patent/US5962024A/en
Priority to AU50061/96A priority patent/AU694849B2/en
Priority to ZA962271A priority patent/ZA962271B/xx
Priority to NZ303683A priority patent/NZ303683A/en
Priority to IL11758296A priority patent/IL117582A/xx
Priority to PCT/FI1996/000164 priority patent/WO1996029058A1/en
Priority to DK96906784T priority patent/DK0817615T3/da
Publication of FI951316L publication Critical patent/FI951316L/fi
Application granted granted Critical
Publication of FI98343B publication Critical patent/FI98343B/fi
Publication of FI98343C publication Critical patent/FI98343C/fi
Priority to NO19973950A priority patent/NO312705B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951316A 1995-03-21 1995-03-21 Peroraalinen formulaatio FI98343C (fi)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio
US08/913,554 US5962024A (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract
ZA962271A ZA962271B (en) 1995-03-21 1996-03-20 Peroral controlled release composition
AT96906784T ATE221771T1 (de) 1995-03-21 1996-03-20 Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes
JP8528112A JPH11502217A (ja) 1995-03-21 1996-03-20 下位胃腸管における制御された放出のための経口用組成物
EP96906784A EP0817615B1 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract
ES96906784T ES2181874T3 (es) 1995-03-21 1996-03-20 Composicion peroral para su liberacion controlada en el tracto gastrointestinal inferior.
CA002213747A CA2213747A1 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract
PT96906784T PT817615E (pt) 1995-03-21 1996-03-20 Composicao oral para libertacao controlada no tracto gastrintestinal inferior
AU50061/96A AU694849B2 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract
DE69622850T DE69622850T2 (de) 1995-03-21 1996-03-20 Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes
NZ303683A NZ303683A (en) 1995-03-21 1996-03-20 Controlled release composition for release in the colon comprising an enteric coating
IL11758296A IL117582A (en) 1995-03-21 1996-03-20 Peroral controlled release composition
PCT/FI1996/000164 WO1996029058A1 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract
DK96906784T DK0817615T3 (da) 1995-03-21 1996-03-20 Peroralt præparat til styret frigivelse i den nedre gastrointestinalkanal
NO19973950A NO312705B1 (no) 1995-03-21 1997-08-27 Peroral sammensetning for kontrollert frigjöring i nedre gastrointestinaltrakt, samt fremgangsmåter til fremstilling derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI951316 1995-03-21
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio

Publications (4)

Publication Number Publication Date
FI951316A0 FI951316A0 (fi) 1995-03-21
FI951316L FI951316L (fi) 1996-09-22
FI98343B true FI98343B (fi) 1997-02-28
FI98343C FI98343C (fi) 1997-06-10

Family

ID=8543092

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio

Country Status (16)

Country Link
US (1) US5962024A (fi)
EP (1) EP0817615B1 (fi)
JP (1) JPH11502217A (fi)
AT (1) ATE221771T1 (fi)
AU (1) AU694849B2 (fi)
CA (1) CA2213747A1 (fi)
DE (1) DE69622850T2 (fi)
DK (1) DK0817615T3 (fi)
ES (1) ES2181874T3 (fi)
FI (1) FI98343C (fi)
IL (1) IL117582A (fi)
NO (1) NO312705B1 (fi)
NZ (1) NZ303683A (fi)
PT (1) PT817615E (fi)
WO (1) WO1996029058A1 (fi)
ZA (1) ZA962271B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
JP2006501310A (ja) * 2002-08-29 2006-01-12 アクティブバイオティクス インコーポレイティッド クロストリジウム・ディフィシレの感染およびそれに関係する疾患を治療するための方法および試薬
US20050025829A1 (en) * 2003-07-29 2005-02-03 Kim Cherng-Ju Controlled drug release tablets
US7410978B2 (en) * 2003-11-04 2008-08-12 Supernus Pharmaceuticals, Inc. Once daily dosage forms of trospium
AU2004289222B2 (en) 2003-11-04 2010-01-21 Supernus Pharmaceuticals Inc. Compositions of quaternary ammonium containing bioavailability enhancers
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
KR100866720B1 (ko) 2004-12-27 2008-11-05 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매 약물의 안정화 방법
WO2007008305A1 (en) * 2005-07-08 2007-01-18 Cherng-Ju Kim Asymmetrically coated tablet
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US20080139526A1 (en) * 2006-12-06 2008-06-12 Donald Treacy Modified release dosage forms of amoxicillin
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US7713549B2 (en) * 2006-06-30 2010-05-11 Board Of Trustees Of The University Of Arkansas Extended release perforated tablet
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2739465C (en) 2008-10-03 2017-01-31 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
CN102988318A (zh) * 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
CA3008794C (en) 2012-03-29 2021-03-16 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
RU2015140610A (ru) 2013-03-14 2017-04-17 ТЕРАБАЙОМ, ЭлЭлСи Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
US10940116B2 (en) * 2017-10-25 2021-03-09 Chiesi Farmaceutici S.P.A. Delayed release deferiprone tablets and methods of using the same
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
JPH0334928A (ja) * 1989-06-29 1991-02-14 Teikoku Seiyaku Kk 潰瘍性大腸炎およびクローン病治療用経口投与製剤
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning

Also Published As

Publication number Publication date
DE69622850T2 (de) 2003-04-24
FI98343C (fi) 1997-06-10
AU5006196A (en) 1996-10-08
NO312705B1 (no) 2002-06-24
AU694849B2 (en) 1998-07-30
ZA962271B (en) 1996-09-30
PT817615E (pt) 2002-12-31
FI951316A0 (fi) 1995-03-21
NO973950D0 (no) 1997-08-27
DK0817615T3 (da) 2002-11-25
CA2213747A1 (en) 1996-09-26
ATE221771T1 (de) 2002-08-15
IL117582A (en) 2000-02-29
NZ303683A (en) 1998-07-28
WO1996029058A1 (en) 1996-09-26
NO973950L (no) 1997-08-27
EP0817615B1 (en) 2002-08-07
DE69622850D1 (de) 2002-09-12
IL117582A0 (en) 1996-07-23
ES2181874T3 (es) 2003-03-01
FI951316L (fi) 1996-09-22
EP0817615A2 (en) 1998-01-14
JPH11502217A (ja) 1999-02-23
US5962024A (en) 1999-10-05

Similar Documents

Publication Publication Date Title
FI98343B (fi) Peroraalinen formulaatio
ATE251899T1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
DE69719774D1 (de) Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
CA2268868A1 (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
ATE291901T1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
ATE260649T1 (de) Pharmazeutische formulierung und dosierform bestehend aus polysacchariden zur kontrollierten wirkstoff-freisetzung im dickdarm
ATE345781T1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
BR9806174A (pt) Péletes tendo um núcleo revestido com um antifúngico e um polìmero
NZ260365A (en) Controlled release drug delivery device; solid core, delay coating, semi-permeable membrane, outer enteric coating
NZ335063A (en) Immediate wettability water soluble film or water soluble layer for oral application
NO975218L (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
IL102851A (en) Stabilized controlled release formulations having acrylic polymer coating and their production
WO2002024174A3 (en) Sustained release composition containing clarithromycin
ATE389389T1 (de) Mehrfach beschichete pharmazeutische dosierungsform
ATE235232T1 (de) Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
WO1996029058B1 (en) Peroral composition for controlled release in the lower gastrointestinal tract
CA2271569A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2271560A1 (en) Pharmaceutical dosage form for colonic delivery
BR9612800A (pt) Forma de dosagem farmacêutica para distribuição colÈnica.
NO992350L (no) Farmas°ytisk doseringsform med multiple enteriske polymerbelegg for avlevering i tykktarmen
BR9612801A (pt) Forma de dosagem farmacêutica com múltiplos revestimentos de polìmeros entéricos para o fornecimento colÈnico.
NO992349L (no) Farmas°ytisk doseform for avlevering i tykktarmen

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired